Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Pseudoprogression As Adverse Event of Chimeric Antigen Receptor T Cell Therapy

Blood (2023) 142 (Supplement 1): 6935.

https://doi.org/10.1182/blood-2023-189047

Published: 2023

Journal Articles

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia

Blood (2023) 141 (13): 1640–1644.

https://doi.org/10.1182/blood.2022017249

Published: 2023

Includes: Supplemental data

Journal Articles

Expression of CD20 Affects Early MRD Response to Rituximab in Adult B Cell Precursor Lymphoblastic Leukemia of the GMALL 08/2013 Trial

Monika Szczepanowski, Johanna Richter, Miriam Kelm, Heiko Trautmann, Britta Kehden, Matthias Ritgen, Christoph Faul, Kathrin Nachtkamp, Björn Steffen, Andreas Viardot, Johannes Gärtner, Johannes Duell, Claudia D. Baldus, Stefan Schwartz, Nicola Goekbuget, Monika Brüggemann

Blood (2021) 138 (Supplement 1): 2301.

https://doi.org/10.1182/blood-2021-150375

Published: 2021

Journal Articles

Molecular Subtypes with Distinct Clinical Phenotypes and Actionable Targets in Adult B Cell Precursor ALL Treatment According to GMALL Protocols

Lorenz Bastian, Sonja Hänzelmann, Martin Neumann, Alina Hartmann, Thomas Burmeister, Stefan Schwartz, Walter Fiedler, MD, Mustafa Kondakci, MD, Andreas Viardot, Professor Dr, Folker Schneller, Christoph Faul, MD, Max S. Topp, MD, Sören Franzenburg, Andre Franke, Heiko Trautmann, PhD, Nicola Goekbuget, MD, Monika Brüggemann, MD, Claudia D Baldus, MD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-143032

Published: 2020

Journal Articles

Molecular Subgroups of T Cell Acute Lymphoblastic Leukemia in Adults Treated According to GMALL Protocols

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-141921

Published: 2020

Journal Articles

CD20 Expression and Response to Rituximab Treatment in B-Cell Precursor Lymphoblastic Leukemia - Results of the GMALL 08/2013 Trial

Monika Szczepanowski, PhD, Johanna Richter, Britta Kehden, Matthias Ritgen, MD, Heiko Trautmann, PhD, Henrik Knecht, PhD, Mustafa Kondakci, MD, Christoph Faul, MD, Björn Steffen, MD, Andreas Viardot, MD, Michael Kneba, Dieter Hoelzer, MD PhD, Nicola Goekbuget, MD, Monika Brüggemann

Blood (2018) 132 (Supplement 1): 1409.

https://doi.org/10.1182/blood-2018-99-114673

Published: 2018

Journal Articles

The IG/TR Next Generation Marker Screening Developed within Euroclonality-NGS Consortium Is Successful in 94% of Acute Lymphoblastic Leukemia Samples

Michaela Kotrova, MD PhD, Henrik Knecht, PhD, Dietrich Herrmann, Martin Schwarz, Karin Olsen, Heiko Trautmann, PhD, Nicola Goekbuget, MD, Christiane Pott, Nikos Darzentas, PhD, Monika Brüggemann

Blood (2018) 132 (Supplement 1): 2830.

https://doi.org/10.1182/blood-2018-99-112828

Published: 2018

Journal Articles

Hematopoietic stem cell involvement in BCR-ABL1– positive ALL as a potential mechanism of resistance to blinatumomab therapy

Inga Nagel, Marius Bartels, Johannes Duell, Hans-Heinrich Oberg, Sandra Ussat, Henrike Bruckmueller, Oliver Ottmann, Heike Pfeifer, Heiko Trautmann, Nicola Gökbuget, Almuth Caliebe, Dieter Kabelitz, Michael Kneba, Heinz-August Horst, Dieter Hoelzer, Max S. Topp, Ingolf Cascorbi, Reiner Siebert, Monika Brüggemann

Blood (2017) 130 (18): 2027–2031.

https://doi.org/10.1182/blood-2017-05-782888

Published: 2017

Includes: Supplemental data

Journal Articles

Subclonal IKZF1 Deletions Indicate a Multiclonal Evolution In BCR-ABL1-Positive B-Cell Precursor ALL

Verena Boehm, PhD, Annett Lebenatus, Marius Bartels, Inga Nagel, PhD, Heiko Trautmann, PhD, Nicola Gökbuget, MD, Dieter Hoelzer, MD, Heike Pfeifer, MD, Reiner Siebert, MD, Michael Kneba, MD, Oliver Ottmann, MD, Monika Brüggemann, MD

Blood (2013) 122 (21): 1327.

https://doi.org/10.1182/blood.V122.21.1327.1327

Published: 2013

Journal Articles

A Comparative Analysis Of Next-Generation Sequencing and Real-Time Quantitative PCR For Minimal Residual Disease Detection In Follicular Lymphomas

Christiane Pott, M.D. Ph.D., Luigia Monitillo, Elisa Genuardi, Barbara Mantoan, Heiko Trautmann, PhD, Michael Kneba, MD, Monika Brüggemann, MD, Malek Faham, MD, PhD, Marco Ladetto

Blood (2013) 122 (21): 4293.

https://doi.org/10.1182/blood.V122.21.4293.4293

Published: 2013

Journal Articles

Next-Generation Sequencing and Real-Time Quantitative PCR For Quantification Of Low-Level Minimal Residual Disease In Acute Lymphoblastic Leukemia Of Adults

Monika Brüggemann, MD, Matthias Ritgen, MD, Marco Ladetto, Francois Pepin, Heiko Trautmann, Victoria Carlton, PhD, Dieter Hoelzer, MD, Nicola Gökbuget, MD, Michael Kneba, MD, Malek Faham, MD, PhD, Christiane Pott, M.D. Ph.D.

Blood (2013) 122 (21): 351.

https://doi.org/10.1182/blood.V122.21.351.351

Published: 2013

Journal Articles

Integrated Somatic Mutation and DNA Methylation Analysis Reveal Genomic and Epigenomic Co-Evolution In Follicular Lymphomas

Markus Loeffler, Prof MD PhD, Markus Kreuz, Andrea Haake, Dirk Hasenclever, PhD, Heiko Trautmann, PhD, Christian Arnold, Karsten Winter, Wolfram Klapper, René Scholtysik, Maciej Rosolowski, PhD, Steve Hoffmann, Ole Ammerpohl, Monika Szczepanowski, Dietrich Herrmann, Ralf Kueppers, Prof, Christiane Pott, M.D. Ph.D., Reiner Siebert, MD

Blood (2013) 122 (21): 502.

https://doi.org/10.1182/blood.V122.21.502.502

Published: 2013

Journal Articles

Next-Generation Sequencing and Real-Time Quantitative PCR for Minimal Residual Disease (MRD) Detection Using the Immunoglobulin Heavy Chain Variable Region: A Methodical Comparison in Acute Lymphoblastic Leukemia (ALL), Mantle Cell Lymphoma (MCL) and Multiple Myeloma (MM)

Marco Ladetto, MD, Monika Bruggemann, Simone Ferrero, MD, Francois Pepin, Daniela Drandi, PhD, Luigia Monitillo, PhD, Antonio Palumbo, MD, Roberto Passera, PhD, Mario Boccadoro, MD, Victoria Carlton, PhD, Heiko Trautmann, Malek Faham, MD, PhD, Christiane Pott

Blood (2012) 120 (21): 788.

https://doi.org/10.1182/blood.V120.21.788.788

Published: 2012

Journal Articles

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, Claus-Rainer Bartram, Renate Arnold, Rainer Fietkau, Mathias Freund, Arnold Ganser, Wolf-Dieter Ludwig, Georg Maschmeyer, Harald Rieder, Stefan Schwartz, Hubert Serve, Eckhard Thiel, Monika Brüggemann, Dieter Hoelzer

Blood (2012) 120 (9): 1868–1876.

https://doi.org/10.1182/blood-2011-09-377713

Published: 2012

Includes: Supplemental data

Journal Articles

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Blood (2011) 118 (1): 139–147.

https://doi.org/10.1182/blood-2011-01-330795

Published: 2011

Includes: Supplemental data

Journal Articles

Multidrug resistance–associated protein 4 ( MRP4 ) gene polymorphisms and treatment response in adult acute lymphoblastic leukemia

Monika Brüggemann, Heiko Trautmann, Dieter Hoelzer, Michael Kneba, Nicola Gökbuget, Thorsten Raff

Blood (2009) 114 (26): 5400–5401.

https://doi.org/10.1182/blood-2009-09-243741

Published: 2009

Journal Articles

Evidence for Antigen-Driven Development of Molecularly Classified Burkitt Lymphomas.

Heiko Trautmann, PhD, Anastasia Hadzidimitriou, PhD, Nikos Darzentas, PhD, Wolfram Klapper, MD, Reiner Siebert, MD, Hilmar Berger, MD, Monika Szczepanowski, MD, Michael Kneba, MD, PhD, Claudia Philipp, PhD, Ralf Küppers, PhD, Kostas Stamatopoulos, MD, Christiane Pott, MD

Blood (2009) 114 (22): 317.

https://doi.org/10.1182/blood.V114.22.317.317

Published: 2009

Journal Articles

An Activating Mutation (Ser525Pro) within the Transactivation Domain of REL in Two Patients with Human B-Cell Lymphomas Enhances REL ’s In Vitro Transforming Activity.

Heiko Trautmann, Daniel T. Starczynowski, Christiane Pott, Lana Harder, Norbert Arnold, Reiner Siebert, Michael Kneba, Thomas D. Gilmore

Blood (2005) 106 (11): 2617.

https://doi.org/10.1182/blood.V106.11.2617.2617

Published: 2005

Journal Articles

Significant Differences in the IGVH and BCL6 Mutation Status in Aggressive B-Cell Lymphomas with and without MYC Breakpoints.

Christiane Pott, Heiko Trautmann, Lana Harder, Michael Kneba, Reiner Siebert, on behalf of the MMML-Network

Blood (2005) 106 (11): 161.

https://doi.org/10.1182/blood.V106.11.161.161

Published: 2005

NARROW

Pseudoprogression As Adverse Event of Chimeric Antigen Receptor T Cell Therapy

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia

Expression of CD20 Affects Early MRD Response to Rituximab in Adult B Cell Precursor Lymphoblastic Leukemia of the GMALL 08/2013 Trial

Molecular Subtypes with Distinct Clinical Phenotypes and Actionable Targets in Adult B Cell Precursor ALL Treatment According to GMALL Protocols

Molecular Subgroups of T Cell Acute Lymphoblastic Leukemia in Adults Treated According to GMALL Protocols

CD20 Expression and Response to Rituximab Treatment in B-Cell Precursor Lymphoblastic Leukemia - Results of the GMALL 08/2013 Trial

The IG/TR Next Generation Marker Screening Developed within Euroclonality-NGS Consortium Is Successful in 94% of Acute Lymphoblastic Leukemia Samples

Hematopoietic stem cell involvement in BCR-ABL1– positive ALL as a potential mechanism of resistance to blinatumomab therapy

Subclonal IKZF1 Deletions Indicate a Multiclonal Evolution In BCR-ABL1-Positive B-Cell Precursor ALL

A Comparative Analysis Of Next-Generation Sequencing and Real-Time Quantitative PCR For Minimal Residual Disease Detection In Follicular Lymphomas

Next-Generation Sequencing and Real-Time Quantitative PCR For Quantification Of Low-Level Minimal Residual Disease In Acute Lymphoblastic Leukemia Of Adults

Integrated Somatic Mutation and DNA Methylation Analysis Reveal Genomic and Epigenomic Co-Evolution In Follicular Lymphomas

Next-Generation Sequencing and Real-Time Quantitative PCR for Minimal Residual Disease (MRD) Detection Using the Immunoglobulin Heavy Chain Variable Region: A Methodical Comparison in Acute Lymphoblastic Leukemia (ALL), Mantle Cell Lymphoma (MCL) and Multiple Myeloma (MM)

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Multidrug resistance–associated protein 4 ( MRP4 ) gene polymorphisms and treatment response in adult acute lymphoblastic leukemia

Evidence for Antigen-Driven Development of Molecularly Classified Burkitt Lymphomas.

An Activating Mutation (Ser525Pro) within the Transactivation Domain of REL in Two Patients with Human B-Cell Lymphomas Enhances REL ’s In Vitro Transforming Activity.

Significant Differences in the IGVH and BCL6 Mutation Status in Aggressive B-Cell Lymphomas with and without MYC Breakpoints.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only